Adaptive Biotechnologies ADPT Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on trailing twelve months.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's gross margin?
- Adaptive Biotechnologies (ADPT) reported gross margin of 75.3% in Q1 2026.
- How has Adaptive Biotechnologies's gross margin changed year-over-year?
- Adaptive Biotechnologies's gross margin increased by 20.3% year-over-year, from 62.5% to 75.3%.
- What is the long-term trend for Adaptive Biotechnologies's gross margin?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's gross margin has grown at a -0.8% compound annual growth rate (CAGR), from 77.1% to 74.2%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.